Concepedia

Jacob Valiyaveettil

JV

Statistics

Publications

7

Citations

165

H-Index

7

Active since

2009

Affiliations

University of Alabama at Birmingham(Current)

Southern Research Institute

University of South Alabama

Auburn University

Samford University

Jacob Valiyaveettil is an author at University of Alabama at Birmingham specializing in pharmacology, life sciences, and molecular oncology.

Publications per year

2009–2025

7

Publications

7

Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling

Bing Zhu, Ashley S. Lindsey, Nan Li et al. · Oncotarget · 2017 · 47 citations · Full text

Life Sciences, Oncology, Pharmacology +15

Unique Functional and Structural Properties of the LRRK2 Protein ATP-binding Pocket

Zhiyong Liu, Robert A. Galemmo, Kyle Fraser et al. · Journal of Biological Chemistry · 2014 · 32 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

New Insights into the Design of Inhibitors of Human <i>S</i>-Adenosylmethionine Decarboxylase: Studies of Adenine C<sup>8</sup> Substitution in Structural Analogues of <i>S</i>-Adenosylmethionine

Diane E. McCloskey, Shridhar Bale, John A. Secrist et al. · Journal of Medicinal Chemistry · 2009 · 28 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +17

Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin

Kevin J. Lee, Wen‐Chi Chang, Xi Chen et al. · Cancer Prevention Research · 2021 · 18 citations · Full text

Medicine, Oncology, Pharmacology +11

ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma

Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh et al. · Molecular Cancer · 2025 · 16 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 7